Shakespeare Wealth Management’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-14,128
Closed -$353K 74
2019
Q4
$353K Buy
14,128
+32
+0.2% +$799 0.19% 54
2019
Q3
$352K Buy
14,096
+93
+0.7% +$2.32K 0.2% 53
2019
Q2
$349K Buy
+14,003
New +$347K 0.23% 52

Other funds holding IBDM

Shakespeare Wealth Management's IBDM Position: Q1 2020 in Review

Shakespeare Wealth Management sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q1 2020, closing a stake of 14,128 shares — an estimated $353K sold.

Shakespeare Wealth Management first reported a position in IBDM in Q2 2019 and held it in 3 quarters. The position peaked at $353K in Q4 2019. 188 funds tracked by Wall St. Rank hold IBDM as of Q1 2020.

  • Shakespeare Wealth Management reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q1 2020 after selling out during the quarter.
  • Shakespeare Wealth Management sold 14,128 iShares iBonds Dec 2021 Term Corporate ETF shares in Q1 2020, an estimated $353K.
  • Shakespeare Wealth Management first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q2 2019 and held it in 3 quarters.
  • Shakespeare Wealth Management's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $353K in Q4 2019.
  • 188 funds tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q1 2020.

Based on Shakespeare Wealth Management's 13F filing for Q1 2020, filed 1 Apr 2020.